D-0387-2019 Class II

Recalled by Allergan, PLC. — Madison, NJ

FDA drug recall D-0387-2019 was initiated by Allergan, PLC. on Dec 20, 2018 and is designated Class II. Reason for recall: GMP Deviations: A silicone particulate was noted in Ozurdex. Affected quantity: 133,716 Cartons.

Recall details

Product Type
Drugs
Report Date
Jan 16, 2019
Initiation Date
Dec 20, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
133,716 Cartons

Product description

OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07

Reason for recall

GMP Deviations: A silicone particulate was noted in Ozurdex.

Distribution pattern

Product was distributed to various accounts throughout the United States including VA and Government Accounts

Code information

E78689, exp. date 06/21/2019 E78726, exp. date 06/29/2019 E78729, exp. date 07/01/2019 E78894, exp. date 08/09/2019 E79157, exp. date 09/05/2019 E79233, exp. date 09/15/2019 E79366, exp. date 10/06/2019 E79891, exp. date 12/07/2019 E80122, exp. date 01/18/2020 E80216, exp. date 02/06/2020 E81080, exp. date 05/09/2020 E81083, exp. date 05/22/2020 E81273, exp. date 05/31/2020 E81344, exp. date 06/21/2020 E82526, exp. date 12/11/2020 E82638, exp. date 12/20/2020 E82738, exp. date 01/18/2021 E82741, exp. date 01/23/2021 E82847, exp. date 01/29/2021 E82852, exp. date 02/01/2021 E83029, exp. date 02/26/2021 E83364, exp. date 04/18/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0387-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0387-2019. Report a data issue: hello@regdatalab.com.